RxDoctor Payments DataLook up a doctor →

Johannes Coetzee, MD

Foot and Ankle Surgery · Edina, MNNPI 1891729000

Payments from drug & device makers

$5,333,963in general payments, 2019–2025

Across 444 payments — averaging $12,013 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$1.7M
  • Johnson & Johnson$1M
  • Responsive Arthroscopy Inc$620K
  • Depuy Synthes Products, Inc.$618K
  • Arthrex$571K
  • Smith+Nephew$548K
  • plus $316K from 12 others
$22,750in research payments, 2019–2025

Across 20 payments — averaging $1137.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$23K

What the payments were for

  • Royalty or licence$1,743,14837%
  • Consulting fees$125,3203%
  • Speaking & faculty fees$111,7672%
  • Travel & lodging$18,0390%
  • Food & beverage$6,9690%
  • Education$1,5790%
  • Ownership interest$1,650,00035%
  • Other$1,009,63622%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,333,963 in reported general payments places this provider in the 95th percentile of 102 foot and ankle surgery providers in Minnesota.

See all foot and ankle surgery providers in Minnesota

Medicare billing

Part B allowed, 2024
$156,285
Medicare patients
316
Services billed
1,554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib28$362
Meloxicam22$215
Cephalexin20$118
Amoxicillin13$10

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Edina

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →